Literature DB >> 921259

Lack of effect of methenamine in suppression of, or prophylaxis against, chronic urinary infection.

B Vainrub, D M Musher.   

Abstract

Methenamine is frequently prescribed for patients who have chronic urinary infection to suppress bacterial growth during active infection or to prevent recurrence once an infection has been brought under control. We have examined the effect of methenamine mandelate and ascorbic acid on bacteriuria in para- and quadriplegics from a spinal cord unit. Patients with indwelling urinary catheters and those on a program of intermittent catheterization were included. No suppressive or prophylactic effect of this regimen was observed in any of our patients. Methenamine does not appear to be an effective antimicrobial agent in subjects who have an indwelling urinary catheter or in patients with spinal cord injury who are on intermittent catheterization. Since there appears to be reason to question the efficacy of methenamine in situations in which it is usually prescribed, evidence should be sought for a therapeutic effect in other cases. If no benefit is observed, the drug should not be used.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 921259      PMCID: PMC429988          DOI: 10.1128/AAC.12.5.625

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  Prevention of recurrent urinary tract infections in girls.

Authors:  N H HOLLAND; C D WEST
Journal:  Am J Dis Child       Date:  1963-06

2.  The generation of formaldehyde from methenamine. Effect of urinary flow and residual volume.

Authors:  D M Musher; D P Griffith; Y Richie
Journal:  Invest Urol       Date:  1976-03

3.  A controlled study of antimicrobial prophylaxis of recurrent urinary infection in women.

Authors:  G K Harding; A R Ronald
Journal:  N Engl J Med       Date:  1974-09-19       Impact factor: 91.245

4.  Methenamine hippurate in the treatment of urinary tract infections.

Authors:  A Kasanen; E Mustakallio; E H Koskinen; V Soini
Journal:  Ann Clin Res       Date:  1974-10

5.  Generation of formaldehyde from methenamine: effect of pH and concentration, and antibacterial effect.

Authors:  D M Musher; D P Griffith
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

6.  Prevention of recurrent bacteriuria with continuous chemotherapy.

Authors:  R B Freeman; L Bromer; F Brancato; S I Cohen; C F Garfield; R J Griep; E J Hinman; J A Richardson; R H Thurm; C Urner; W M Smith
Journal:  Ann Intern Med       Date:  1968-10       Impact factor: 25.391

7.  The prolonged use of methenamine hippurate in the treatment of chronic urinary tract infection.

Authors:  A R Gerstein; R Okun; H C Gonick; H I Wilner; C R Kleeman; M H Maxwell
Journal:  J Urol       Date:  1968-12       Impact factor: 7.450

8.  Antibacterial correlates of urine drug levels of hexamethylenetetramine and formaldehyde.

Authors:  H Miller; E Phillips
Journal:  Invest Urol       Date:  1970-07

9.  Chemotherapy of chronic urinary tract infections with methenamine hippurate.

Authors:  H Seneca; H H Zinsser; P Peer
Journal:  J Urol       Date:  1967-06       Impact factor: 7.450

10.  Quantitative urinalysis. Diagnosing urinary tract infection in men.

Authors:  D M Musher; S B Thorsteinsson; I I Airola VM
Journal:  JAMA       Date:  1976-11-01       Impact factor: 56.272

  10 in total
  7 in total

Review 1.  Catheter-associated infections: pathogenesis affects prevention.

Authors:  Barbara W Trautner; Rabih O Darouiche
Journal:  Arch Intern Med       Date:  2004-04-26

Review 2.  Washout policies in long-term indwelling urinary catheterisation in adults.

Authors:  Ashley J Shepherd; William G Mackay; Suzanne Hagen
Journal:  Cochrane Database Syst Rev       Date:  2017-03-06

3.  Prevention of recurrent acute cystitis by methenamine hippurate: double blind controlled crossover long term study.

Authors:  S Cronberg; C O Welin; L Henriksson; S Hellsten; K M Persson; P Stenberg
Journal:  Br Med J (Clin Res Ed)       Date:  1987-06-13

Review 4.  Methenamine hippurate for preventing urinary tract infections.

Authors:  Bon San B Lee; Tushar Bhuta; Judy M Simpson; Jonathan C Craig
Journal:  Cochrane Database Syst Rev       Date:  2012-10-17

5.  Randomized double-blind study of prophylactic methenamine hippurate treatment of patients with indwelling catheters.

Authors:  A Norberg; B Norberg; U Parkhede; H Gippert; K Lundbeck
Journal:  Eur J Clin Pharmacol       Date:  1980-11       Impact factor: 2.953

6.  Effect of urinary acidifiers on formaldehyde concentration and efficacy with methenamine therapy.

Authors:  M C Nahata; B A Cummins; D C McLeod; S W Schondelmeyer; R Butler
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

7.  The effect of methenamine on vascular development: Experimental investigation using in vivo and insilico methods.

Authors:  Hadi Tavakkoli; Masoud Imani; Mohammad Rahchamani Seyyed; Mohsen Rezvani
Journal:  Int J Reprod Biomed       Date:  2020-08-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.